Dark

Check out our API

DNAY
Codex DNA, Inc. Common Stock
stock NASDAQ

Inactive

Jan 3, 2023

1.30USD+8.333%(+0.10)19,956

Pre-market

0.00USD-100.000%(-1.20)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 18, 2022

08:09AM EST Codex DNA Showcases Potential Of Groundbreaking SOLA Enzymatic DNA Synthesis Approach To Accelerate Development Of Vaccines And Therapeutics Benzinga

08:03AM EST -- Proprietary short oligo ligation assembly (SOLA) technology used to enzymatically synthesize DNA fragments for the construction of full-length H1 and N1 genes from influenza A virus -- Initial performance results show potentially significant quality, time, and cost advantages compared to traditional chemical synthesis and alternative enzymatic DNA synthesis approaches GlobeNewswire Inc

Jan 10, 2022

06:53AM EST Codex DNA Signs Early Access Collaboration And Licensing Agreement With Pfizer To Further Develop Codex DNA's Novel Enzymatic DNA Synthesis Technology For Pfizer's Use In Its Research And Development Of mRNA-based Vaccines And Biotherapies Benzinga

06:50AM EST -- Pfizer and Codex DNA agree to strategic, multiyear, early access research collaboration, leveraging Codex DNAs novel enzymatic DNA synthesis (EDS) technology -- Pfizers successful development and commercialization of licensed products could result in milestone payments in excess of $100 million GlobeNewswire Inc

Dec 30, 2021

12:14PM EST Shares of synthetic biology company Codex DNA Inc. (DNAY) are rising 12 percent on Thursday's trading after the company announced that it has entered into a research collaboration and license agreement with pharmaceutical company Pfizer Inc.(PFE). RTTNews

Dec 23, 2021

08:05AM EST Codex DNA Highlights Release Of New Full-Length Synthetic Genome Of SARS-CoV-2 Virus For Omicron Benzinga

08:03AM EST Codex DNA Expands Catalog of COVID-19 Tools with Release of GlobeNewswire Inc

Nov 29, 2021

08:14AM EST Codex DNA Announces Commercial Availability Of Automated mRNA Synthesis Kit With Integrated Capping Technology For BioXp System Benzinga

08:03AM EST -- Proven CleanCap reagent technology from TriLink BioTechnologies delivers significant time and cost savings for mRNA-based vaccine and therapeutic applications -- Codex DNA scientists to share latest data and showcase mRNA synthesis solutions at upcoming mRNA conference GlobeNewswire Inc

Nov 11, 2021

08:03AM EST Codex DNA to Present at the Jefferies London Healthcare Conference GlobeNewswire Inc

Nov 10, 2021

08:23AM EST The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance Benzinga

06:59AM EST Codex DNA Clocks Q3 Sales Growth Of 75%; Acquires Eton Bioscience For $13M Benzinga

Nov 9, 2021

06:24PM EST Codex DNA Reports Purchase Of Eton Bioscience For $13MIn Cash Benzinga

06:23PM EST Codex DNA Q3 EPS $(0.34) Misses $(0.28) Estimate, Sales $2.80M Miss $2.93M Estimate Benzinga

11:25AM EST Earnings Scheduled For November 9, 2021 Benzinga

Nov 2, 2021

07:00AM EDT Codex DNA to Report Third Quarter 2021 Financial Results on GlobeNewswire Inc

Sep 22, 2021

07:45AM EDT The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs Benzinga

Sep 21, 2021

08:20AM EDT The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data Benzinga

Sep 2, 2021

08:20AM EDT The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab Benzinga

Aug 20, 2021

07:45AM EDT The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data Benzinga

Aug 13, 2021

07:43AM EDT The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO Benzinga

Aug 12, 2021

08:09AM EDT The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma Benzinga

Aug 10, 2021

04:38PM EDT Codex DNA Q2 EPS $(1.06) Down From $(0.82) YoY, Sales $2.85M Beat $2.55M Estimate Benzinga

04:05AM EDT Earnings Scheduled For August 10, 2021 Benzinga

Aug 5, 2021

07:33AM EDT Codex DNA Announces Synthetic Biology Collaboration with U.S. Department of Agriculture to Combat Citrus Greening Disease Benzinga

07:00AM EDT Codex DNA Announces Synthetic Biology Collaboration with U.S. GlobeNewswire Inc

Aug 3, 2021

07:00AM EDT Codex DNA to Report Second Quarter 2021 Financial Results on GlobeNewswire Inc

Jul 21, 2021

09:41AM EDT Codex DNA Shares Move Higher On Licensing, Supply Deal With TriLink For mRNA Capping Tech Benzinga

07:10AM EDT Codex DNA Announces Licensing And Supply Deal With TriLink Biotechnologies For CleanCap mRNA Capping Technology Benzinga

07:07AM EDT Codex DNA Announces Licensing and Supply Deal with TriLink GlobeNewswire Inc

Jul 19, 2021

10:41AM EDT 'These 3 Stocks May Be Reaching a Bottom; Analysts Say 'Buy'' -TipRanks, Mentions UpHealth, Femasys, Codex DNA Benzinga

Jul 15, 2021

08:08AM EDT The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs Benzinga

Jul 14, 2021

07:48AM EDT The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues Benzinga

Jul 13, 2021

10:13AM EDT Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2021 Benzinga

09:08AM EDT UPDATE: KeyBanc On Codex DNA Overweight Initiation: Firm Sees Novel Pure-Play On The High-Growth Synthetic Biology Market And Expects Approximately 100% Revenue Growth Per Year Benzinga

06:32AM EDT Jefferies Initiates Coverage On Codex DNA with Buy Rating, Announces Price Target of $23 Benzinga

06:29AM EDT Cowen & Co. Initiates Coverage On Codex DNA with Outperform Rating Benzinga

04:54AM EDT Keybanc Initiates Coverage On Codex DNA with Overweight Rating, Announces Price Target of $30 Benzinga

Jul 1, 2021

08:07AM EDT The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts Benzinga

Jun 22, 2021

04:10PM EDT Codex DNA Announces Closing of Initial Public Offering and Full GlobeNewswire Inc

Jun 18, 2021

10:49AM EDT Codex DNA Shares Open For Trade At $20; IPO Priced At $16/Share Benzinga

10:42AM EDT Codex DNA Shares Indicating $20.80 On 308K Shares Benzinga

09:25AM EDT Codex DNA Shares Will Open For Quote At 10:10 a.m. EDT, Expected To Open For Trade After 10:20 a.m. EDT; IPO Priced At $16/Share Benzinga

Jun 17, 2021

10:16PM EDT Codex DNA Announces Pricing of Initial Public Offering GlobeNewswire Inc

Jun 14, 2021

09:15AM EDT Codex DNA Announces Launch of Initial Public Offering GlobeNewswire Inc

Share